RxDoctor Payments Data

Shab Benz, PA

Physician Assistant · Warwick, NYNPI 1316969397

Payments from drug & device makers

$443in general payments, 2019–2025

Across 20 payments — averaging $22.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bridgebio Pharma, Inc.$76
  • Boston Scientific$70
  • Edwards Lifesciences$55
  • E.r. Squibb & Sons, L.L.C.$44
  • Amgen$41
  • Novo Nordisk$39
  • plus $119 from 7 others

What the payments were for

  • Food & beverage$42496%
  • Education$194%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$443 in reported general payments places this provider in the 60th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Medicare billing

Part B allowed, 2024
$2,757
Medicare patients
28
Services billed
37

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol109$136,461
OzempicSemaglutide131$130,893
EntrestoSacubitril/Valsartan66$97,699
EliquisApixaban71$92,117
JardianceEmpagliflozin64$90,112
XareltoRivaroxaban56$80,858
Repatha SureclickEvolocumab46$35,063
WegovySemaglutide25$32,853
MounjaroTirzepatide11$20,142
Nebivolol Hcl115$9,217
Ezetimibe271$8,412
Rosuvastatin Calcium298$6,570
Dabigatran EtexilateDabigatran Etexilate Mesylate15$4,852
Valsartan125$3,300
Metoprolol Succinate192$3,101

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Wegovy$39$163,746156 claims
AstraZenecaFarxiga$14$136,461109 claims
NovartisEntresto$15$97,69966 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Warwick

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →